These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32274856)

  • 21. Machine-Learning Algorithms Predict Graft Failure After Liver Transplantation.
    Lau L; Kankanige Y; Rubinstein B; Jones R; Christophi C; Muralidharan V; Bailey J
    Transplantation; 2017 Apr; 101(4):e125-e132. PubMed ID: 27941428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiplication product of Model for End-stage Liver Disease and Donor Risk Index as predictive models of survival after liver transplantation.
    Khalaileh A; Khoury T; Harkrosh S; Nowotny Y; Massarwa M; Safadi R; Mor E; Nakache R; Abu Gazala S; Merhav H
    Eur J Gastroenterol Hepatol; 2019 Sep; 31(9):1116-1120. PubMed ID: 30870222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. D-MELD as a predictor of early graft mortality in adult-to-adult living-donor liver transplantation.
    Ikegami T; Imai D; Wang H; Yoshizumi T; Yamashita Y; Ninomiya M; Iguchi T; Bekki Y; Shirabe K; Maehara Y
    Transplantation; 2014 Feb; 97(4):457-62. PubMed ID: 24531822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.
    Chok KS; Fung JY; Chan AC; Dai WC; Sharr WW; Cheung TT; Chan SC; Lo CM
    Ann Surg; 2017 Jan; 265(1):173-177. PubMed ID: 28009743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detrimental graft survival of size-mismatched graft for high model for end-stage liver disease recipients in liver transplantation.
    Fukazawa K; Nishida S; Pretto EA; Vater Y; Reyes JD
    J Hepatobiliary Pancreat Sci; 2016 Jul; 23(7):406-13. PubMed ID: 27108389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of artificial neural networks as a methodology for donor-recipient matching for liver transplantation.
    Ayllón MD; Ciria R; Cruz-Ramírez M; Pérez-Ortiz M; Gómez I; Valente R; O'Grady J; de la Mata M; Hervás-Martínez C; Heaton ND; Briceño J
    Liver Transpl; 2018 Feb; 24(2):192-203. PubMed ID: 28921876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allocation of liver grafts worldwide - Is there a best system?
    Tschuor C; Ferrarese A; Kuemmerli C; Dutkowski P; Burra P; Clavien PA;
    J Hepatol; 2019 Oct; 71(4):707-718. PubMed ID: 31199941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lessons Learned From Review of a Single Center Experience With 500 Consecutive Liver Transplants in a Region With Insufficient Deceased-Donor Support.
    Yankol Y; Mecit N; Kanmaz T; Cimsit B; Cakaloglu Y; Acarli K; Kalayoglu M
    Exp Clin Transplant; 2016 Apr; 14(2):191-200. PubMed ID: 26030810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Results of liver transplantation from old donors.
    Dudek K; Kornasiewicz O; Remiszewski P; Zieniewicz K; Wróblewski T; Krawczyk M
    Transplant Proc; 2014 Oct; 46(8):2762-5. PubMed ID: 25380912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Graft selection strategy in adult-to-adult living donor liver transplantation: When both hemiliver grafts meet volumetric criteria.
    Kurihara T; Yoshizumi T; Yoshida Y; Ikegami T; Itoh S; Harimoto N; Ninomiya M; Uchiyama H; Okabe H; Kimura K; Kawanaka H; Shirabe K; Maehara Y
    Liver Transpl; 2016 Jul; 22(7):914-22. PubMed ID: 26953726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Actual Risk of Using Very Aged Donors for Unselected Liver Transplant Candidates: A European Single-center Experience in the MELD Era.
    Bertuzzo VR; Cescon M; Odaldi F; Di Laudo M; Cucchetti A; Ravaioli M; Del Gaudio M; Ercolani G; D'Errico A; Pinna AD
    Ann Surg; 2017 Feb; 265(2):388-396. PubMed ID: 28059967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction.
    Croome KP; Marotta P; Wall WJ; Dale C; Levstik MA; Chandok N; Hernandez-Alejandro R
    Transplant Proc; 2012 Jun; 44(5):1303-6. PubMed ID: 22664005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era.
    Dutkowski P; Oberkofler CE; Slankamenac K; Puhan MA; Schadde E; Müllhaupt B; Geier A; Clavien PA
    Ann Surg; 2011 Nov; 254(5):745-53; discussion 753. PubMed ID: 22042468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Left lobe living donor liver transplantation in adults: What is the safety limit?
    Ikegami T; Yoshizumi T; Sakata K; Uchiyama H; Harimoto N; Harada N; Itoh S; Nagatsu A; Soejima Y; Maehara Y
    Liver Transpl; 2016 Dec; 22(12):1666-1675. PubMed ID: 27540888
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and Validation of a Nomogram for Predicting Incidence of Early Allograft Dysfunction Following Liver Transplantation.
    Yang L; Xin EY; Liao B; Lai LJ; Han M; Wang XP; Ju WQ; Wang DP; Guo ZY; He XS
    Transplant Proc; 2017; 49(6):1357-1363. PubMed ID: 28736007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting patient survival after liver transplantation using evolutionary multi-objective artificial neural networks.
    Cruz-Ramírez M; Hervás-Martínez C; Fernández JC; Briceño J; de la Mata M
    Artif Intell Med; 2013 May; 58(1):37-49. PubMed ID: 23489761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Bayesian methodology to improve prediction of early graft loss after liver transplantation derived from the liver match study.
    Angelico M; Nardi A; Romagnoli R; Marianelli T; Corradini SG; Tandoi F; Gavrila C; Salizzoni M; Pinna AD; Cillo U; Gridelli B; De Carlis LG; Colledan M; Gerunda GE; Costa AN; Strazzabosco M;
    Dig Liver Dis; 2014 Apr; 46(4):340-7. PubMed ID: 24411484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How can we utilize livers from advanced aged donors for liver transplantation for hepatitis C?
    Uemura T; Nikkel LE; Hollenbeak CS; Ramprasad V; Schaefer E; Kadry Z
    Transpl Int; 2012 Jun; 25(6):671-9. PubMed ID: 22487509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic limitations of the Eurotransplant-Donor Risk Index in liver transplantation.
    Reichert B; Kaltenborn A; Goldis A; Schrem H
    J Negat Results Biomed; 2013 Dec; 12():18. PubMed ID: 24365258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Model for end-stage liver disease score in the first 3 weeks after liver transplantation as a predictor for long-term outcome.
    Khandoga A; Iskandarov E; Angele M; Gerbes A; Frey L; Ağayev B; Jauch KW; Werner J; Guba M
    Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):153-8. PubMed ID: 26545081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.